Likely a divide and conquer scenario for many of them. That is crazy though. Certainly raising awareness about the portfolio. Also, I am sure AMBS is gauging interest and 'selling' the idea of Lympro. I would bet a bunch of the companies have Alzheimer clinical trials. Pre-launch activities in my opinion. 45-50 face to face sales calls.